205 related articles for article (PubMed ID: 35101271)
1. Outcomes in Patients With Asymptomatic Aortic Stenosis (from the Evolut Low Risk Trial).
Merhi WM; Heiser J; Deeb GM; Yakubov SJ; Lim DS; Bladergroen M; Tadros P; Zorn G; Byrne T; Kirshner M; Huang J; Reardon MJ
Am J Cardiol; 2022 Apr; 168():110-116. PubMed ID: 35101271
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(14):1-148. PubMed ID: 33240455
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
Thyregod HGH; Jørgensen TH; Ihlemann N; Steinbrüchel DA; Nissen H; Kjeldsen BJ; Petursson P; De Backer O; Olsen PS; Søndergaard L
Eur Heart J; 2024 Apr; 45(13):1116-1124. PubMed ID: 38321820
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.
Reardon MJ; Heijmen RH; Van Mieghem NM; Williams MR; Yakubov SJ; Watson D; Kleiman NS; Conte J; Chawla A; Hockmuth D; Petrossian G; Robinson N; Kappetein AP; Li S; Popma JJ
JAMA Cardiol; 2019 Aug; 4(8):810-814. PubMed ID: 31215985
[TBL] [Abstract][Full Text] [Related]
5. Propensity-Matched Comparison of Evolut-R Transcatheter Aortic Valve Implantation With Surgery in Intermediate-Risk Patients (from the SURTAVI Trial).
Yakubov SJ; Van Mieghem NM; Reardon MJ; Serruys PW; Gada H; Mumtaz M; Deeb GM; Kodali S; George I; Windecker S; Kleiman N; Chetcuti SJ; Sanchez C; Dauerman HL; Li S; Popma JJ
Am J Cardiol; 2020 Sep; 131():82-90. PubMed ID: 32723555
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes of TAVI or SAVR in men and women with aortic stenosis at intermediate operative risk: a post hoc analysis of the randomised SURTAVI trial.
Van Mieghem NM; Reardon MJ; Yakubov SJ; Heiser J; Merhi W; Windecker S; Makkar RR; Cheng W; Robbins M; Fail P; Feinberg E; Stoler RC; Hebeler R; Serruys PW; Popma JJ
EuroIntervention; 2020 Nov; 16(10):833-841. PubMed ID: 32715995
[TBL] [Abstract][Full Text] [Related]
7. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement.
Jørgensen TH; Thyregod HGH; Ihlemann N; Nissen H; Petursson P; Kjeldsen BJ; Steinbrüchel DA; Olsen PS; Søndergaard L
Eur Heart J; 2021 Aug; 42(30):2912-2919. PubMed ID: 34179981
[TBL] [Abstract][Full Text] [Related]
8. Propensity score matched comparison of transcatheter aortic valve implantation versus conventional surgery in intermediate and low risk aortic stenosis patients: A hint of real-world.
Castrodeza J; Amat-Santos IJ; Blanco M; Cortes C; Tobar J; Martin-Morquecho I; López J; Di Stefano S; Rojas P; Varela-Falcon LH; Gomez I; San Roman JA
Cardiol J; 2016; 23(5):541-551. PubMed ID: 27439368
[TBL] [Abstract][Full Text] [Related]
9. [Outcome comparison of different therapy procedures in surgical high-risk elderly patients with severe aortic stenosis].
Ye YQ; Wang YT; Li Z; Wang MY; Xu HY; Zhang WJ; Liu QR; Niu GN; Wu YJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):13-18. PubMed ID: 28100340
[No Abstract] [Full Text] [Related]
10. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients.
Piazza N; Kalesan B; van Mieghem N; Head S; Wenaweser P; Carrel TP; Bleiziffer S; de Jaegere PP; Gahl B; Anderson RH; Kappetein AP; Lange R; Serruys PW; Windecker S; Jüni P
JACC Cardiovasc Interv; 2013 May; 6(5):443-51. PubMed ID: 23702009
[TBL] [Abstract][Full Text] [Related]
11. Transcatheter Aortic Valve Implantation in Patients With Severe, Symptomatic Aortic Valve Stenosis at Intermediate Surgical Risk: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2020; 20(2):1-121. PubMed ID: 32194880
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter Aortic Valve Implantation for Treatment of Aortic Valve Stenosis: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(19):1-94. PubMed ID: 27990197
[TBL] [Abstract][Full Text] [Related]
13. Comparing functional and quality of life outcomes in transcatheter aortic valve implantation and surgical aortic valve replacement for aortic stenosis: a systematic review and meta-analysis.
Duffy M; Lynch A; Reddin C; Judge C; O'Donnell M; Murphy R
BMC Cardiovasc Disord; 2023 Oct; 23(1):519. PubMed ID: 37880616
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in high-risk patients: comparison of transcatheter aortic valve implantation with surgical aortic valve replacement.
Amonn K; Stortecky S; Brinks H; Gahl B; Windecker S; Wenaweser P; Carrel T; Huber C
Eur J Cardiothorac Surg; 2013 Jan; 43(1):34-41; discussion 41-2. PubMed ID: 22531274
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Valve Durability and Outcomes of Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in Patients With Severe Symptomatic Aortic Stenosis and Less-Than-High-Risk for Surgery.
Tzamalis P; Alataki S; Bramlage P; Schmitt C; Schymik G
Am J Cardiol; 2020 Apr; 125(8):1202-1208. PubMed ID: 32085868
[TBL] [Abstract][Full Text] [Related]
16. Comparison of early clinical outcomes following transcatheter aortic valve implantation versus surgical aortic valve replacement versus optimal medical therapy in patients older than 80 years with symptomatic severe aortic stenosis.
Im E; Hong MK; Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Shim CY; Chang HJ; Shim JK; Kwak YL; Lee S; Chang BC; Jang Y
Yonsei Med J; 2013 May; 54(3):596-602. PubMed ID: 23549802
[TBL] [Abstract][Full Text] [Related]
17. Transcatheter Aortic Valve Implantation (TAVI) Versus Surgical Aortic Valve Replacement for Aortic Stenosis (SAVR): A Cost-Comparison Study.
Shah KK; Elder D; Nguyen MTH; Turner L; Doyle M; Woldendorp K; Seco M; Law CK; Wilson MK; Keech A; Ng MK; Morton RL
Heart Lung Circ; 2021 Dec; 30(12):1918-1928. PubMed ID: 34226106
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing the choice between transcatheter and surgical treatment of severe aortic stenosis in patients younger than 80 years: Results from the OBSERVANT study.
Tarantini G; Nai Fovino L; D'Errigo P; Rosato S; Barbanti M; Tamburino C; Ranucci M; Santoro G; Badoni G; Seccareccia F;
Catheter Cardiovasc Interv; 2020 May; 95(6):E186-E195. PubMed ID: 31423704
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in German Severe Aortic Stenosis Patients at Low Surgical Mortality Risk.
Kuck KH; Leidl R; Frankenstein L; Wahlers T; Sarmah A; Candolfi P; Shore J; Green M
Adv Ther; 2023 Mar; 40(3):1031-1046. PubMed ID: 36622552
[TBL] [Abstract][Full Text] [Related]
20. Predicting 5-Year Clinical Outcomes After Transcatheter or Surgical Aortic Valve Replacement (a Risk Score from the SURTAVI Trial).
van Bergeijk KH; Wykrzykowska JJ; van Mieghem NM; Windecker S; Sondergaard L; Gada H; Li S; Hanson T; Deeb GM; Voors AA; Reardon MJ
Am J Cardiol; 2023 Aug; 200():78-86. PubMed ID: 37307783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
